Epilepsy Management

The authors of a Cochrane review of lacosamide add-on therapy for drug-resistant partial epilepsy have concluded that the medication performs better than placebo and is effective at daily doses of at least 200 mg.
The website helps veterans with epilepsy to interact with each other and to report their adverse events and improvement, according to a recent article.
Patients with treatment-resistant epilepsy may benefit from a treatment regimen that includes cannabidiol (Epidiolex), a compound in medical marijuana that does not contain psychoactive properties.
Philadelphia, PA—Multiple formulations and generic equivalents of anti­epileptic drugs are prevalent, and choosing between them can help optimize seizure control and minimize adverse effects, said Carl W. Bazil, MD, PhD, Director, Comprehensive Epilepsy Center, Columbia University Medical Center, New York, at the 2014 American Academy of Neurology (AAN) meeting.
Philadelphia, PA—Patients with breakthrough seizures despite adherence to antiepileptic drugs have much higher emergency department and inpatient utilization compared with patients without breakthrough seizures, according to a poster presented during the 2014 meeting of the American Academy of Neurology by Charles Makin, MS, MBA, Health Economics and Outcomes Research, IMS Health, and colleagues.
A recent spate of US Food and Drug Administration (FDA) approvals for epilepsy medications—4 in all—has fortified the armamentarium of drugs available for the treatment of seizure disorders.

Results 1 - 6 of 6
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology